Zentalis Pharmaceuticals (ZNTL)
(Delayed Data from NSDQ)
$1.52 USD
+0.03 (2.01%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.54 +0.02 (1.32%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Zentalis Pharmaceuticals, Inc. has a market cap of $107.48M, which represents its share price of $1.49 multiplied by its outstanding shares number of 72.14M. As a small-cap company, ZNTL's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ZNTL 1.52 +0.03(2.01%)
Will ZNTL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ZNTL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZNTL
Zentalis Pharmaceuticals (ZNTL) Loses -46.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zentalis Pharmaceuticals (ZNTL) Upgraded to Strong Buy: What Does It Mean for the Stock?
ZNTL: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for January 9th
Other News for ZNTL
Is ZNTL ready to move higher? Pocket Pivot shows up after climbing 2.01%
Stochastic Buy Signal appears for ZNTL after 4.93% move
The technical outlook for ZNTL is unchanged after sideways trading on September 17
H.C. Wainwright Remains a Buy on Zentalis Pharmaceuticals (ZNTL)
New Downtrend appears for ZNTL after 2.07% move